| Samrat Pharmachem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530125 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE103E01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 220.67 |
Market Cap(₹Cr) : 70.74 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 79.76 | 71.77 | 63.43 | 78.87 | 75.65 | 71.20 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 79.76 | 71.77 | 63.43 | 78.87 | 75.65 | 71.20 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.99 | -0.31 | 0.40 | 0.05 | 0.69 | -0.11 |
| Total Income | 80.75 | 71.47 | 63.83 | 78.92 | 76.34 | 71.10 |
| Total Expenditure | 78.86 | 73.02 | 64.08 | 79.23 | 75.53 | 71.08 |
| PBIDT | 1.89 | -1.55 | -0.26 | -0.31 | 0.82 | 0.02 |
| Interest | 0.11 | 0.14 | 0.13 | 0.26 | 0.44 | 0.22 |
| PBDT | 1.77 | -1.69 | -0.38 | -0.57 | 0.38 | -0.20 |
| Depreciation | 0.19 | 0.19 | 0.19 | 0.18 | 0.17 | 0.16 |
| Tax | 0.19 | 0.00 | 0.03 | 0.00 | 0.00 | 0.09 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.52 | 0.16 | -0.14 | -0.16 | 0.44 | -0.05 |
| Reported Profit After Tax | 0.88 | -2.04 | -0.46 | -0.59 | -0.23 | -0.40 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.88 | -2.04 | -0.46 | -0.59 | -0.23 | -0.40 |
| EPS (Unit Curr.) | 2.84 | -6.59 | -1.49 | -1.90 | -0.74 | -1.29 |
| EPS (Adj) (Unit Curr.) | 2.84 | -6.59 | -1.49 | -1.90 | -0.74 | -1.29 |
| Calculated EPS (Unit Curr.) | 2.84 | -6.59 | -1.49 | -1.90 | -0.74 | -1.29 |
| Calculated EPS (Adj) (Unit Curr.) | 2.84 | -6.59 | -1.49 | -1.90 | -0.74 | -1.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 11.34 | -26.36 | -5.95 | -7.60 | -2.96 | -5.17 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 11.34 | -26.36 | -5.95 | -7.60 | -2.96 | -5.17 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 2.37 | -2.16 | -0.41 | -0.39 | 1.08 | 0.03 |
| PBDTM(%) | 2.22 | -2.35 | -0.60 | -0.72 | 0.50 | -0.28 |
| PATM(%) | 1.10 | -2.84 | -0.73 | -0.75 | -0.30 | -0.56 |
